ASML: Margin Expansion Is Just Getting Started

This is less about one quarter and more about confirmation that leading-edge semiconductor capex is still being rationed, not cut. That matters because ASML sits at the bottleneck of the node-transition cycle: when EUV demand stays firm, the rest of the supply chain tends to reprice as if a multi-year capacity wave is now locked in. The market should reward the company with a higher-quality multiple than broader semi-capex peers because the installed-base and service mix can cushion the inevitable volatility in new tool shipments.

The main second-order winners are the foundries and memory names that need to secure capacity ahead of AI demand: TSM, Samsung, SK Hynix, and MU. But there is an offsetting loser set in 6-12 months: if DRAM/HBM additions come through aggressively, the memory shortage narrative can morph into oversupply faster than consensus expects, which is typically when the equity beta in memory names compresses even while equipment orders remain healthy. That creates a subtle trap: the best near-term read-through is not necessarily the best 12-month P&L.

The key risk is that the market may already own the story as a generic AI-capex proxy, while the real upside depends on customers converting interest into revised 2025-26 capex guides and firm order intake. If those follow-through signals do not appear over the next 1-2 quarters, the stock can stall despite a clean beat. Also watch export-control headlines and any pause in lead-time commitments; those are the fastest falsifiers because they hit both revenue visibility and multiple support almost immediately.